As of May 19, 2025, the CAH stock has a P/E ratio of 23.89. The calculation is based on the latest EPS of $6.44 and the stock price of $153.86 per share. An increase of 3.2% has been observed in the PE ratio compared to its average of 23.1 of the past four quarters.
The mean historical PE ratio of Cardinal Health over the last ten years is 34.82. The current 23.89 price-to-earnings ratio is 31% less than the historical average. Analyzing the last ten years, CAH's PE ratio reached its highest point in the Mar 2019 quarter at 267.5, with a price of $48.15 and an EPS of $0.18. The Jun 2019 quarter saw the lowest point at 10.35, with a price of $47.1 and an EPS of $4.55.
Maximum annual increase: 255.42% in 2013
Maximum annual decrease: -82.62% in 2019
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 28.25 | -62.06% | $98.32 | $3.48 |
2023 | 74.46 | N/A | $94.57 | $1.27 |
2022 | N/A | N/A | $52.27 | -$3.37 |
2021 | 27.32 | N/A | $57.09 | $2.09 |
2020 | N/A | N/A | $52.19 | -$12.61 |
2019 | 10.35 | -82.62% | $47.1 | $4.55 |
2018 | 59.55 | 210.32% | $48.83 | $0.82 |
2017 | 19.19 | 7.27% | $77.92 | $4.06 |
2016 | 17.89 | -21.74% | $78.01 | $4.36 |
2015 | 22.86 | 14.01% | $83.65 | $3.66 |
2014 | 20.05 | -58.37% | $68.56 | $3.42 |
2013 | 48.16 | 255.42% | $47.2 | $0.98 |
2012 | 13.55 | -17.98% | $42 | $3.1 |
2011 | 16.52 | -12.03% | $45.42 | $2.75 |
2010 | 18.78 | 97.89% | $33.61 | $1.79 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 21.39 | -2.33% | $137.77 | $6.44 |
Dec 2024 | 21.9 | 4.04% | $118.27 | $5.4 |
Sep 2024 | 21.05 | -25.49% | $110.52 | $5.25 |
Jun 2024 | 28.25 | -35.62% | $98.32 | $3.48 |
Mar 2024 | 43.88 | 23.19% | $111.9 | $2.55 |
Dec 2023 | 35.62 | -65.95% | $100.8 | $2.83 |
Sep 2023 | 104.6 | 40.48% | $86.82 | $0.83 |
Jun 2023 | 74.46 | 68.65% | $94.57 | $1.27 |
Mar 2023 | 44.15 | N/A | $75.5 | $1.71 |
Dec 2022 | N/A | N/A | $76.87 | -$4.69 |
Sep 2022 | N/A | N/A | $66.68 | -$4.02 |
Jun 2022 | N/A | N/A | $52.27 | -$3.37 |
Mar 2022 | N/A | N/A | $56.7 | -$3.54 |
Dec 2021 | 26.82 | 111.01% | $51.49 | $1.92 |
Sep 2021 | 12.71 | -53.48% | $49.46 | $3.89 |
You can ether set your own Fair P/E multiple or use one of the automatically calculated Fair P/E multiples.
PE Ratio is an attempt to estimate a fair PE ratio of a stock based on its earnings and growth rate.
This formula is a modified version of the classic Graham-Dodd Formula (V= EPS x (8.5+2g)), originally developed by Benjamin Graham, to calculate the fair price of a stock based on its earnings and growth rate.
The formula we have created is an adaptation of this approach, designed to maintain a balance between simplicity and growth sensitivity.
It is calculated using the following formula:
IF g < 5: Fair PE = b
IF g >= 5: Fair PE = m × g
Here’s what each part of the formula means:
g: Growth is calculated as the average of the three-year average EPS growth rate and the one-year EPS growth rate (annually). This approach provides a balanced measure of growth by factoring in both the long-term growth trend and the most recent annual growth performance. If one of the growth metrics is not available, the remaining metric is used to determine growth. The fair P/E value is capped at 100 to prevent distortions caused by extreme EPS growth rates, such as those resulting from large percentage increases from a low base.
m: This is the long term historical median PEG (Price/Earnings to Growth) ratio of the overall market. It serves as a benchmark, adjusting the Fair PE based on typical market conditions.
b: Base PE (static value set to 8). If the company's growth rate is less than 5, the Fair PE is set at a conservative baseline of 8. This is because declining companies generally deserve a lower PE ratio.
Fixed: The Fair PE ratio for all data points is calculated using a single, constant average EPS growth rate, determined based on the most recent period. This means that the same growth rate is applied to all historical data points. Dynamic: The Fair PE ratio for each historical data point is calculated using the trailing average EPS growth rate specific to that point in time. This means that for each data point, the corresponding trailing EPS growth rate is used, ensuring that the Fair PE ratio reflects the growth conditions that were relevant at that specific point in history.
The current PE ratio of CAH is under its 3, 5 and 10-year averages.
CAH's PE ratio is less than its peer stocks MCK and TFX, but it is above CVS's and HSIC's. Cardinal Health's current PE ratio of 23.89 is less than the average of its peers, which is 24.71.
Stock name | PE ratio | Market cap |
---|---|---|
HLF Herbalife Nutrition Ltd | 2.48 | $704.78M |
CVS CVS HEALTH Corp | 15.18 | $80.63B |
HSIC Henry Schein Inc | 22.57 | $8.9B |
CAH Cardinal Health Inc | 24.03 | $36.94B |
MCK Mckesson Corp | 27.81 | $89.98B |
TFX Teleflex Inc | 38.91 | $5.61B |
PINC Premier Inc | 41.25 | $1.9B |
OMI Owens & Minor Inc | N/A | $559.28M |
As of May 19, 2025, CAH stock has a price to earnings ratio of 23.89.
The 3-year average PE ratio for CAH stock is 43.92.
The 5-year average PE ratio for CAH stock is 33.54.
Over the last ten years, the Mar 2019 quarter recorded the highest quarterly PE ratio at 267.5.
CAH's current price to earnings ratio is 31% below its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (May 19, 2025), Cardinal Health's share price is $153.86. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $6.44. Therefore, Cardinal Health's price to earnings ratio for today is 23.89. PE RATIO(23.89) = STOCK PRICE($153.86) / TTM EPS($6.44)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.